Stock comparison
Merck &
Mettler-Toledo International
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
MRK
Merck &
Market cap
$302.33B
Sector
Healthcare
MTD
Mettler-Toledo International
Market cap
$22.29B
Sector
Healthcare
Overall winner
Mettler-Toledo International MTD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | MRK | MTD | Winner |
|---|---|---|---|
| Warren Buffett | 64C | 69B | MTD |
| Benjamin Graham | 78B | 65B | MRK |
| Philip Fisher | 63C | 63C | Tie |
| Peter Lynch | 68B | 66B | MRK |
| Joel Greenblatt | 34F | 68B | MTD |
| Charlie Munger | 68C | 74B | MTD |
| Terry Smith | 55D | 70B | MTD |
Side-by-side metrics
| Metric | MRK | MTD |
|---|---|---|
| Market cap | $302.33B | $22.29B |
| P/E (TTM) | 31.5x | 25.3x |
| EV/EBIT | 13.9x | 21.6x |
| ROIC (TTM) | 13.34% | 36.09% |
| Gross margin | 75.91% | 57.79% |
| Net margin | 13.62% | 21.4% |
| Revenue CAGR 5y | 7.45% | 2.01% |
| EPS CAGR 5y | 9.06% | 6.12% |
| Debt / Equity | 1.1x | - |
| Dividend yield | 2.91% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
MRK leads on
- Dividend yield2.91%vs 0.0%+100%
- Market cap$302.33Bvs $22.29B+93%
- Revenue CAGR 5y7.45%vs 2.01%+73%
- EV/EBIT13.9xvs 21.6x+36%
MTD leads on
- Debt / Equity-vs 1.1x+102%
- ROIC (TTM)36.09%vs 13.34%+63%
- Net margin21.4%vs 13.62%+36%
- P/E (TTM)25.3xvs 31.5x+20%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.